Richard Aplenc, MD, PhD, MSCE

Filter

RECRUITMENT

Photo of Richard Aplenc

Richard Aplenc, MD, PhD, MSCE

Professor of Pediatrics and Epidemiology

Dr. Aplenc is a Professor of Pediatrics in the Department of Pediatrics with a secondary appointment in the Department of Biostatistics, Informatics, and Epidemiology. His research focus is in pediatric acute myeloid leukemia (AML) with ongoing clinical epidemiology and translational research projects. Dr. Aplenc's current clinical epidemiology research focuses on chemotherapy associated cardiac toxicity and disparities in treatment outcomes for children with AML. From a translational research standpoint, he lead efforts to identify genetic predictors of anthracycline associated cardiac toxicity and to characterize the AML blast cell surfaceome to identify novel therapeutic targets for pediatric AML. From a clinic trial perspective, he co-Chair the Pediatric Blood and Marrow Transplant Consortium trial for an anti-CD33 chimeric antigen receptor (CAR) and is also the PI of a local anti-CD123 CAR trial. In addition, he serves as the Vice-Chair of the Children's Oncology Group AML Strategy Committee.

 

Content Area Specialties

Pediatric Acute Myeloid Leukemia

About Us

To understand health and disease today, we need new thinking and novel science —the kind  we create when multiple disciplines work together from the ground up. That is why this department has put forward a bold vision in population-health science: a single academic home for biostatistics, epidemiology and informatics. 

© 2023 Trustees of the University of Pennsylvania. All rights reserved.. | Disclaimer

Follow Us